Takeda Pharmaceutical Co Ltd logo

Takeda Pharmaceutical Co Ltd

NEW
TSE:4502 (Japan)   Ordinary Shares
円 5,480 +57 (+1.08%) Jul 17
At Loss
P/B:
1.14
Market Cap:
円 8.53T ($ 52.58B)
Enterprise V:
円 12.78T ($ 78.74B)
Volume:
5.07M
Avg Vol (2M):
4.05M
Trade In:

Takeda Pharmaceutical Co Ltd’s share price is 円5480. Its GF Value is 円4541.22. Based on the relationship between the current stock price and the GF Value, GuruFocus believes Takeda Pharmaceutical Co Ltd stock is .

The GF Value represents the current intrinsic value of a stock derived from our proprietary algorithm. It is based primarily on the historical multiples of where the stocks have been traded and the future growth of the business, adjusted for the past returns and growth. The GF Value has been verified by backtesting and daily updated model portfolios.

GF Value Growth:

In addition to considering the current valuation, the growth potential of a company's value is equally important. Companies with faster growth rates tend to increase their value more quickly. Therefore, it's essential to look at the Price-to-Future GF Value ratios as well. The results are shown below:

Price: 円5480 GF Value Price/GF Value
Current 円4541.22 1.21
Next FY1 End 円4634.97 1.18
Next 12 Month 円4664.63 1.17
Next FY2 End 円4723.93 1.16
Correlation Analysis
Summary:

GuruFocus performed a correlation analysis comparing Takeda Pharmaceutical Co Ltd's stock price with key financial metrics: revenue per share, book value per share, EPS without NRI, and operating cash flow per share.

The analysis reveals the strongest correlation between Takeda Pharmaceutical Co Ltd's stock price and Revenue per share, with a coefficient of 72%. This is followed by a 71% correlation with Book Value per share. Takeda Pharmaceutical Co Ltd’s stock price shows no significant correlation with Operating Cash Flow per share. Takeda Pharmaceutical Co Ltd’s stock price shows no significant correlation with Earnings without NRI per share.

Historical Trends of Key Valuation Ratios
GF Value of Related Companies